Sequential changes in serum cytokines and chemokines in a rat model of Japanese encephalitis

NeuroImmunoModulation

Volumn 17, Issue 6, 2010, Pages 411-416

  Misra, Usha Kant ^a   Srivastava, Ruchi ^a   Kalita, Jayantee ^a   Khan, Mohammad Yahiya ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b BABASAHEB BHIMRAO AMBEDKAR UNIVERSITY   (India)

Author keywords

Chemokine; Cytokines; Immunopathogenesis; Japanese encephalitis virus; Viral encephalitis

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; IMMUNE RESPONSE; INFLAMMATION; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MALE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MICE; PREDICTIVE VALUE OF TESTS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 77952839764     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000291438     Document Type: Article

References (29)

1. Tsai TF: New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine 2000; 18(suppl 2):1-25.
2. Mathur A, Bharadwaj M, Kulshreshtha R, Rawat S, Jain A, Chaturvedi UC: Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol 1988; 69: 423-432.
3. Solomon T, Winter PM: Neurovirulence and host factors in flavivirus encephalitis - evidence from clinical epidemiology. Arch Virol Suppl 2004; 18: 161-170.
4. Mathur A, Arora KL, Chaturvedi UC: Host defence mechanisms against Japanese encephalitis virus infection in mice. J Gen Virol 1983; 64: 805-811.
5. Desai A, Ravi V, Chandramukhi A, Gourie-Devi M: Detection of neutralizing antibodies to Japanese encephalitis virus in the cerebrospinal fluid using a rapid microneutralization test. Serodiagn Immunother Infect Dis 1994; 6: 130-134.
6. Murali-Krishna K, Ravi V, Manjunath R: Protection of adult but not newborn mice against intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus specific T lymphocytes: requirement of L3T4+ cells. J Gen Virol 1996; 77: 705-714.
7. Ramakrishna C, Ravi V, Desai A, Subbakrishna DK, Shankar SK, Chandramuki A: T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse used. J Gen Virol 2003; 84: 1559-1567.
8. Kumar P, Sulochana P, Nirmala G, Haridattatreya M, Satchidanandam V: Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort. J Gen Virol 2004; 85: 1131-1143.
9. Fairweather D, Rose NR: Women and autoimmune diseases. Emerg Infect Dis 2004; 10: 2005-2011.
10. Srivastava R, Kalita J, Khan MY, Misra UK: Free radical generation by neurons in rat model of Japanese encephalitis. Neurochem Res 2009, E-pub ahead of print.
11. Woodruff JF: Viral myocarditis. A review. Am J Pathol 1980; 101: 425-484.
12. Winter PM, Dung NM, Loan HT, Kneen R, Wills B, Thu le T, House D, White NJ, Farrar JJ, Hart CA, Solomon T: Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis 2004; 190: 1618-1626.
13. Burke DS, Morill JC: Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis. J Infect Dis 1987; 155: 797-799.
14. Mistchenko AS, Diez RA, Mariani AL, Robaldo J, Maffey AF, Bayley-Bustamante G, Grinstein S: Cytokines in adenoviral disease in children: association of interleukin-6, interleukin- 8, and tumor necrosis factor alpha levels with clinical outcome. J Pediatr 1994; 124: 714-720.
15. Ghoshal A, Das S, Ghosh S, Mishra MK, Sharma V, Koli P, Sen E, Basu A: Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 2007; 55: 483-496.
16. Saxena V, Mathur A, Krishnani N, Dhole TN: An insufficient anti-inflammatory cytokine response in mice brain is associated with increased tissue pathology and viral load during Japanese encephalitis virus infection. Arch Virol 2008; 153: 283-292.
17. Ogata A, Nagashima K, Hall WW, Ichikawa M, Kimura-Kuroda J, Yasui K: Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. J Virol 1991; 65: 880-886.
18. Saxena V, Mathur A, Krishnani N, Dhole TN: Kinetics of cytokine profile during intraperitoneal inoculation of Japanese encephalitis virus in BALB/c mice model. Microbes Infect 2008; 10: 1210-1217.
19. Burton DR: Antibodies, viruses and vaccines. Nat Rev Immunol 2002; 2: 706-713.
20. Chen CJ, Liao SL, Kuo MD, Wang YM: Astrocytic alteration induced by Japanese encephalitis virus infection. Neuroreport 2000; 11: 1933-1937.
21. Ravi V, Parida S, Desai A, Chandramukhi A, Gourie-Devi M, Grau GE: Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 1997; 51: 132-136.
22. John CC, Panoskaltsis-Mortari A, Opoka RO, Park GS, Orchard PJ, Jurek AM, Idro R, Byarugaba J, Boivin MJ: Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg 2008; 78: 198-205.
23. Banks WA: Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des 2005; 11: 973-984.
24. Deli MA, Descamps L, Dehouck MP, Cecchelli R, Joó F, Abrahám CS, Torpier G: Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res 1995; 41: 717-726.
25. Megyeri P, Abrahám CS, Temesvari P, Kovács J, Vas T, Speer CP: Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 1992; 148: 137-140.
26. Banks WA, Niehoff ML, Zalcman SS: Permeability of the mouse blood-brain barrier to murine interleukin-2: predominance of a saturable efflux system. Brain Behav Immun 2004; 18: 434-442.
27. Banks WA, Ortiz L, Plotkin SR, Kastin AJ: Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991; 259: 988-996.
28. McGavern DB, Homann D, Oldstone MB: T cells in the central nervous system: the delicate balance between viral clearance and disease. J Infect Dis 2002; 186:S145-S151.
29. Griffin DE: Cytokines in the brain during viral infections: clues to HIV-associated dementia. J Clin Invest 1997; 100: 2948-2951.